AFYREN (EPA:ALAFY) | WebDisclosure

Basculer en Français

8763	Companies
156822	Keywords
92383	Articles
84501	Press releases

Home
Companies
AFYREN

BRIEF

published on 07/08/2025 at 17:55, 23 hours 10 minutes ago

AFYREN obtient une subvention de 4 millions d'euros et dévoile une nouvelle stratégie d'investissement

Stratégie D'investissement Capacité De Production Subventions AFYREN Bioraffinerie
BRIEF

published on 07/08/2025 at 17:55, 23 hours 10 minutes ago

AFYREN Secures €4 Million Grant and Unveils New Investment Strategy

Investment Strategy Production Capacity Grants AFYREN Biorefinery
PRESS RELEASE

published on 07/08/2025 at 17:50, 23 hours 15 minutes ago

AFYREN receives €4 million in grants for AFYREN NEOXY and starts new performance-driven investment strategy
AFYREN receives €4 million grants for AFYREN NEOXY, implements new performance-driven investment strategy. Funds support industrial development, optimization, and profitability enhancement

Investment Strategy Industrial Development Grants AFYREN Bio-based Products
BRIEF

published on 06/20/2025 at 17:50, 18 days 23 hours ago

Approbation des résolutions à l'Assemblée Générale 2025 d'AFYREN

Assemblée Générale Quorum Résolutions Approuvées Renouvellements AFYREN
BRIEF

published on 06/20/2025 at 17:50, 18 days 23 hours ago

Approval of resolutions at the 2025 AFYREN General Meeting

General Assembly Quorum Resolutions Approved AFYREN Renewals
PRESS RELEASE

published on 06/20/2025 at 17:45, 18 days 23 hours ago

Informations privilégiées / Autres communiqués
Les actionnaires d’AFYREN approuvent les résolutions lors de l’AGM 2025. 52,76% du capital représenté. Renouvellement des mandats et greentech

Actionnaires Renouvellement Resolutions GreenTech AFYREN
BRIEF

published on 06/17/2025 at 07:40, 22 days 9 hours ago

AFYREN Advances Industrial Strategy with Continuous Production at AFYREN NEOXY

Revenue Growth Plant Expansion Continuous Production Bio-based Acids Industrial Strategy
BRIEF

published on 06/17/2025 at 07:40, 22 days 9 hours ago

AFYREN fait progresser sa stratégie industrielle avec une production continue chez AFYREN NEOXY

Croissance Des Revenus Agrandissement De L'usine Acides Biosourcés Stratégie Industrielle Production Continue
PRESS RELEASE

published on 06/17/2025 at 07:35, 22 days 9 hours ago

AFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production
AFYREN begins new phase of industrial strategy with continuous production at first plant AFYREN NEOXY, accelerating commercialization and securing €165 million in revenue contracts

AFYREN Continuous Production Bio-based Acids Industrial Strategy Revenue Contracts
BRIEF

published on 06/17/2025 at 07:35, 22 days 9 hours ago

AFYREN: Launch of continuous production at AFYREN NEOXY

Growth Strategy AFYREN Continuous Production Biorefinery Bio-sourced Acids

1 2 ... 8

Accesswire

Published on 07/09/2025 at 16:00, 1 hour 6 minutes ago

Aeonian Receives Drill Permits for Koocanusa Project, Paving the Way for First Pass Testing of Sedimentary Copper Targets
Published on 07/09/2025 at 14:30, 2 hours 36 minutes ago

Agassi Sports Entertainment Engages IBM to Help Elevate Racquet Sports Experience
Published on 07/09/2025 at 14:30, 2 hours 36 minutes ago

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement
Published on 07/09/2025 at 14:00, 3 hours 6 minutes ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
Published on 07/09/2025 at 14:00, 3 hours 6 minutes ago

Le traitement pour l’acné vulgaire de Bausch Health, Canada Inc., (Pr)CABTREO(MC) (gel de phosphate de clindamycine, d’adapalène et de peroxyde de benzoyle), est maintenant couvert par les régimes publics de l’Ontario, de la Nouvelle Écosse et p

View all ACCESSWIRE

EQS Group

Published on 07/09/2025 at 16:18, 47 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc
Published on 07/09/2025 at 16:08, 57 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 07/09/2025 at 16:07, 58 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 07/09/2025 at 16:06, 59 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Published on 07/09/2025 at 16:05, 1 hour ago

Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc

Les Echos

Published on 07/09/2025 at 10:36, 6 hours 29 minutes ago

Cogelec : Statement on the total number of shares and voting rights provided
Published on 07/09/2025 at 10:36, 6 hours 29 minutes ago

Cogelec : Information relative au nombre total d’actions et de droits de vote
Published on 07/09/2025 at 10:16, 6 hours 49 minutes ago

Nombre total d'actions et droits de vote - juin 2025
Published on 07/09/2025 at 10:16, 6 hours 49 minutes ago

Number of shares and voting rights - June 2025 (In French only)
Published on 07/09/2025 at 08:34, 8 hours 31 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 juin 2025

View all LES ECHOS COMFI WIRE